20 years since FDA approved alcohol addiction drug
It has been 20 years since the FDA last approved a medication specifically for alcohol use disorder.
Snapshot · TED Talks Daily
Can Ozempic end addiction? | Dhruv Khullar | Your Body on Tech
Explore episode
Jun 26, 2026
Where this was said
Dhruv Khullar's TED Talk: GLP-1s and the Science of Addiction
At 13:13 · chapter starts 5:29
The centerpiece of the episode, Khullar's TED Talk opens with Mary — a patient who had failed rehab, AA, and Antabuse before enrolling in an Ozempic clinical trial and achieving sobriety [1] — Dhruv Khullar "Mary had tried rehab, AA, and Antabuse — and failed every time. Then she enrolled in a clinical trial for Ozempic. Within weeks, the cravin…" 05:29 . From there, Khullar unfolds the drug's origin story: discovered in the 1980s but unworkable until a Gila monster researcher found a peptide in lizard venom that lasted hours rather than minutes. That discovery unlocked a class of drugs now showing effects far beyond digestion — specifically in the brain's mesolimbic reward pathway. GLP-1s appear to blunt dopamine spikes across every major addiction: alcohol, cocaine, nicotine, gambling, even social media. One neuroscientist told Khullar this suggests addiction may have a single universal pathology. But Khullar urges caution: these 'moderation molecules' can become desire dampeners, and anhedonia is a real risk. He closes by invoking Aristotle — and then dismantling him: Aristotle never faced Doritos, TikTok, or fentanyl. Moderation today isn't just a virtue; it is, the science suggests, a physiological state [2] — Dhruv Khullar "GLP-1s suggest that Aristotle's moderation, it's not just a virtue, it is a physiological state. It isn't just about character, it is about…" 14:44 .
Mary's Story: How Ozempic Cleared Her Alcohol Noise
Mary had tried rehab, AA, and Antabuse — and failed every time. Then she enrolled in a clinical trial for Ozempic. Within weeks, the craving was gone. She stopped drinking, lost 55 pounds, ended a bad relationship, and started exercising. GLP-1s didn't just treat her addiction; they gave her room to rebuild her life.
From Gila Monster Venom to Addiction Cure: The GLP-1 Origin Story
GLP-1 was discovered in the 1980s, but it broke down in minutes — useless as a drug. The breakthrough came from an unexpected place: Gila monster venom, which contained a similar peptide that could persist for hours. That discovery launched one of the most consequential drug classes in modern medicine.
GLP-1 first discovered in 1980s
GLP-1 (glucagon-like peptide 1) was first discovered in the 1980s and initially studied for diabetes management.
Gila monster venom breakthrough
A scientist studying Gila monsters discovered the lizard's venom contained a GLP-1-like peptide that could persist for hours, catalyzing the GLP-1 drug revolution.
The Universal Addiction Pathway: One Molecule to Rule Them All?
GLP-1s don't just reduce appetite — they appear to dampen dopamine spikes across every major addiction: alcohol, cocaine, nicotine, gambling, even social media. A neuroscientist told Khullar this suggests addiction has a single universal pathology, and GLP-1s may be part of how we fix it.
Calming the Water Without Draining the Pool
GLP-1s blunt the dopamine spikes triggered by cocaine, alcohol, and other addictive substances — but they don't drain dopamine entirely. Mice given GLP-1s and cocaine had smaller dopamine surges but maintained baseline neurotransmitter levels. The drugs moderate without eliminating the will to live.
Similar snapshots
50% of U.S. adults report being lonely
The U.S. Surgeon General's 2023 report on loneliness found that half of American adults report feeling lonely, marking a widespread epidemic of social isolation.
Brain.fm increased focus brainwave activity by 119%
In a peer-reviewed study, Brain.fm's audio technology was shown to increase focus-related brainwave activity by 119%, according to the show's sponsor read.
Wealthier countries have highest rates of anxiety and depression
The Easterlin Paradox shows that wealthier nations — and the wealthiest neighborhoods within them — tend to have the highest rates of anxiety, depression, loneliness, and suicide.
More than 3 in 4 Americans report anxiety or depression
Mental health challenges are nearly universal — BetterHelp's own research found the majority of Americans experiencing symptoms right now.
Medicaid 5-year look-back rule
When applying for Medicaid to cover nursing home costs, there is a 5-year look-back period that can disqualify applicants who gave away or spent down assets.
Pipe broke → hydrogen sulfide studio air
A broken pipe filled the Bad Friends studio with what the hosts identified as hydrogen sulfide — microscopic fecal aeroparticles — that the crew denied smelling.
Robot surgery: 10x less blood loss
Fei-Fei Li's father's liver surgery performed by a da Vinci robot resulted in 10 times less blood loss than a typical open liver surgery, thanks to laparoscopic precision.
115M US adults have prediabetes
Approximately 115 million adults in the US currently have prediabetes, most of whom are unaware, according to the Lingo sponsor segment.
Drug overdose deaths: 110K to 80K to 70K
Drug overdose deaths in the US fell from 110,000 to 80,000 in 2024, and then to roughly 70,000 — the largest single-year drop the CDC has ever recorded.
